Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PVCT will - over the next 2 Weeks and hit - by . In that time frame, PVCT's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
PVCT shares rose +0.93% in Thursday, September 10, 2026's trading session, rising from a previous close of $0.05 to move at $0.05. The stock demonstrated notable intraday movement (see PVCT's key stats for a full breakdown), fluctuating between $0.05 and $0.06, a +10.15% trading range. While recent weeks have seen some volatility, PVCT has managed to secure a -10.00% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 177.62K shares changing hands, 125.55K more than the previous session. This amounted to $9.59K in total market activity.
Will PVCT Continue Its Trend?
According to analyst ratings and projections for PVCT, Provectus Biopharmaceuticals, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PVCT currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the PVCT stock forecast, now is not the best time to buy PVCT stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PVCT covering social and institutional perspectives.
PVCT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PVCT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.73% to 42.72%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.52%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.84%, maintains a neutral outlook for the long term. Insights into PVCT's shareholder base show how institutional investors are positioning themselves during these momentum shifts

